In response to the COVID-19 pandemic, South Korea is moving to establish a national industry strategy to reduce regional inequalities within the country through the Green New Deal. Thus, it is important to closely integrate the aim of reducing greenhouse gas emissions from the Green New Deal with that of reducing deepening regional inequality from the Regionally Balanced New Deal. To accomplish these dual aims, this study provides a collaborative trans-regional R&D strategy and a precise framework with three key dimensions: regional, technological, and organizational. We demonstrate that future mobility is the most important project of the Green New Deal, comprising 1963 nationally funded projects worth USD 1285.4 million. We also illustrate the level of government investment in nationally funded research projects related to future mobility for 17 different regions and seven different technology clusters related to future mobility, and determine which research organizations played an important role in each cluster for all 17 regions between 2015 and 2020. Our results indicate that the capital region and Daejeon have high innovation capability in many future mobility-related research fields, whereas some regions have capabilities in specific research fields such as hydrogen infrastructure, indicating their relative competitiveness.
An international research and development (R&D) collaboration for aging-related projects is necessary to alleviate the severe economic/healthcare/humanitarian challenges of a global aging society. This study presents a practical/systematic framework that enables the provision of information on the research goals, the status of science and technology, and action plans of aging-related program development processes. We used data on aging-related national-funded projects from the United States of America, the European Union, the United Kingdom, Japan, and Korea. We collected data on 6318 national-funded projects, subsequently designating research fields to each project. By analyzing the content of the projects, their representative research fields, and the associated keywords, we assessed the general goals of six different research fields. To recognize the current scientific capabilities of these research fields, we divided the projects by clusters. We provided information on research organizations, specific goals (i.e., project title), project periods, and the funding related to the projects. These may be used by stakeholders in various governments/institutions/industries during future discussions regarding the establishment of an international R&D collaboration strategy. The approach we proposed may facilitate the linkage between knowledge and action during strategy development by maximizing scientific legitimacy, developing consensual knowledge, and minimizing diverging opinions among stakeholders.
Infectious diseases have been continuously and increasingly threatening human health and welfare due to a variety of factors such as globalisation, environmental, demographic changes, and emerging pathogens. In order to establish an interdisciplinary approach for coordinating R&D via funding, it is imperative to discover research trends in the field. In this paper, we apply machine learning methodologies and network analyses to understand how the European Union (EU) and the United States (US) have invested their funding in infectious diseases research utilising an interdisciplinary approach. The purpose of this paper is to use public R&D project data as data and to grasp the research trends of epidemic diseases in the US and EU through scientometric analysis.
Purpose – This study aims to contribute to the comprehension of managerial implications in all the new convergences fields: bioinformation technology (BIT), nanoinformation technology (NIT), nanobiotechnology (NBT) and bioinformation–nanotechnology (BINT). The phenomenon of convergence that significantly impacted economies and societies in the information technology era has continued to be combined with new technologies such as nanotechnology and biotechnology. Many countries have tried to seize the initiative to strengthen the future competitiveness, and it become increasingly important for roles of companies to expand applications of the new convergence. Design/methodology/approach – From a company-based perspective, the study quantifies leading companies’ degree of influence in each convergence field. Findings – However, the result shows that companies’ influences are not mature enough to transfer the initiatives from both the NBT and BINT convergence fields. In addition, this study presents a perceivable framework for companies/institutions by identifying which technological fields the companies/institutions are influential in and what degrees of technological impact are shaped among them. As a result, this allows companies/institutions to recognize their environments squarely. Originality/value – This study applied the replacement process that can reinforce the investigation of the extent to which a firm has a significant ability to influence others directly and indirectly. From the methodology perspective, such replacement can intensely display the structure and the extent of competition among firms. Therefore, the results provide an explicit information to understand the overall business situation. Paper type – Research paper
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.